Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CLDN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PQBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WAC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP205 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HILPDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD83B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on